Signet Therapeutics
PrivateLast Round
Series A
Jan 14, 2026
Total Funding Raised
$50.7M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Signet Therapeutics is a biotechnology company that develops first-in-class targeted cancer therapies using organoids and AI.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Signet Therapeutics Comparables
Compare Signet Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Orakl Oncology | 79% | |
| ProxyBio | 77% | |
| Avatrial | 77% | |
Signet Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 14, 2026 | ||||
| Pre Seed | Dec 3, 2024 | ||||
| Seed | Oct 29, 2021 | ||||
| Pre Seed | May 1, 2021 | ||||
| Angel | Mar 5, 2021 |
Signet Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Yael Capital | Seed |
| Tiantu Capital | Seed, Series A, Pre Seed, Angel |
| Sky9 Capital | Seed, Angel, Pre Seed |
| Blue Ocean Capital Group | Seed, Series A |
| 5Y Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 312% MoM, reaching 3.2K.
- Jul 20, 2026
Open roles increased to 12, 200% of headcount.
Signet Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Signet Therapeutics's valuation, stock price, and market status.